Leena yadav biography samples

Prof Kumar is a founding Co-Director of the pan-university Institute for Sustainability, Professor & Chair in Air Quality and Health, and founding Director of the internationally-leading research centre Global Centre for Clean Air Research (GCARE) at the University of Surrey, UK. He is the founder of successfully running Guildford Living Lab, a Trustee at Zero Carbon Guildford (ZERO), an Adjunct Professor at Trinity College Dublin, Ireland; and a Guest Professor at Southeast University, China.

He joined the Senior Leadership team of the Faculty of Engineering and Physical Sciences as an Associate Dean (International) in 2020 and subsequently took up another senior leadership role to help setup the new pan-University Institute for Sustainability as a founding Co-Director in 2023. As an Associate Dean (International), he worked on implementing the University's Global Strategy and provided leadership to the international agenda, including student recruitment, transforming the PGR international placements through Turing and other mobility schemes, building several successful international research partnerships, coordinated numerous UG and PGT partnerships and joint PhD programmes, and led the QS submission for the University as a 'QS Impact Champion'.

Earlier, he served as a Reader (2015-2017), Senior Lecturer (2012-2015) and Lecturer (2009-2012) before promoting to Chair and Full Professor of Air Quality and Health (2017-) at the University of Surrey. He was the Deputy Director of Research for the Department of Civil & Environmental Engineering during 2018-2021.

An engineer by training, Prof Kumar obtained his PhD (Engineering) from the University of Cambridge (UK) after winning a Cambridge-Nehru Scholarship and Overseas Research Scholarship award. He earned his Master's Degree in Environmental Engineering & Management from the Indian Institute of Technology, Delhi, where he won the ‘Outstanding Postgraduate Student Award’ fo

ABSTRACT

Clinical trials (CT) have been the cornerstones in developing medicines, vaccines, and new interventions. Despite tremendous efforts, a CT cannot succeed without participants’ involvement. Various factors can affect people’s attitude and participation in a CT. Hence, this study was conducted to assess the knowledge and perception of a clinical trial among the participants of a CT at B.P. Koirala Institute of Health Sciences, Dharan, Nepal. This was a population-based descriptive cross-sectional study conducted during 2021–2022. Participants involved in a phase III clinical trial were enrolled, and an in-depth interview was conducted using a semi-structured questionnaire. Demographic information, knowledge and perception about CT were assessed, and a descriptive analysis was done. Among 622 participants, the majority were males (321; 51.6%), literate (587; 94.37%), of indigenous ethnic groups (Janajatis 61.4%), and without previous experience of CT (504; 81.1%). The majority had adequate knowledge (566/622; 91%) and positive perception (595/622; 95.7%) of CT. Most participants (467; 75.1%) had participated in CT to get protection from the particular disease from the provided vaccine and (603; 96.9%) believed CT to benefit mankind. Further studies comparing pre- and post-participation knowledge and perception might be helpful for planning and better management of CTs in such settings.

KEYWORDS: Clinical trial, knowledge, perception, participants, oral cholera vaccine

Introduction

With the paradigm shift created by Evidence-Based Medicine (EBM), clinical trials (CTs) have been the cornerstones in developing medicines, vaccines, and new interventions. National Institute of Health (NIH) defines a clinical trial (CT) as “a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or